CM Plus was introduced at “Japan Innovation Night”.
The Ministry of Economy, Trade and Industry (METI) held the “Japan Innovation Night” on Thursday, June 8, As a side event of the BIO International Convention 2023, one of the world’s largest business matching events in the biotechnology field, in Boston, to promote Japan’s efforts in the biotechnology field.
In the explanation of this “Japan Innovation Night”, CM Plus, as a company in Yokohama City, was introduced a service that supports the expansion of pharmaceutical companies into North America and Japan by the Office of the City of Yokohama Representative to the Americas.
Click here for the CM Plus matching service
Overview of Japan Innovation Night
From news of METI site
As a side event of the BIO International Convention 2023, the world’s largest-class business-matching event in the field of biotechnology held from June 5 (Mon.) to 8 (Thurs.) (local time), 2023, in Boston, the U.S., METI, jointly with the Japan External Trade Organization (JETRO) and CIC, held an event titled Japan Innovation Night to attract people’s attention to Japanese industries’ efforts in the same field, including those by the Government of Japan and startups.
Under the Strategy for Strengthening the Vaccine Development and Production System, on which a Cabinet Decision was made on June 1, 2021, METI launched a Strengthening Program for the Pharmaceutical Startup Ecosystem, taking advantage of a fund of 350 billion yen in total with the aim of supporting drug discovery startups, which are key entities for the development of new drugs.
At the Japan Innovation Night event, representatives of METI, Keidanren and some municipalities delivered speeches, and members of Japanese startups pitched presentations. The startups included one that METI supports in the Strengthening Program noted above .
Through not only leveraging the budget of the Strengthening Program but also activities like this event, METI will strive to encourage business cooperation among companies inside and outside Japan and enhance Japanese startups’ collaboration with overseas ecosystems, thereby building an ecosystem that attracts investments and human resources to drug discovery startups in Japan and, furthermore, dramatically fortifying Japan’s drug discovery capabilities.
At the beginning of the event, Mr. Kishida Fumio, Prime Minister, delivered a speech as a video message, strongly expressing the sentiment that “Now is the time to invest in Japanese pharmaceutical startups.”
